Coloma Jason V
Transaction: 06/23/2026
SELL
Change
-23,865
Price
$26.05
Filing
06/24/2026
Type
SELL
Maze Therapeutics, Inc.
MAZE • Biotechnology
$26.21
▲ +0.34 (+1.31%)
Current price
EarningsLatest report: Mar 31, 2026
HIGHER-RISK PROFILECautionConfidence: 62%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$1.41B
Growth
—
Cash Flow
1/5
Trend
Volatile
Evidence
Manageable debt level · 0.07Healthy liquidity · 15.5Weak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 12, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:36 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$26.21
Change1.31%
Shares Out53.90M
Market Cap$1.41B
Enterprise Value$1.10B
52W Range10.98 - 53.65
Beta2.26
P/E-11.53
P/S70.63
P/B4.13
P/FCF-11.57
EV/Sales55.20
Price$26.21
Change1.31%
Shares Out53.90M
Market Cap$1.41B
Enterprise Value$1.10B
52W Range10.98 - 53.65
Beta2.26
P/E-11.53
P/S70.63
P/B4.13
P/FCF-11.57
EV/Sales55.20
EV/EBITDA-8.75
EV/FCF-9.04
Earnings Yield-8.67%
FCF Yield-8.65%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.07
Current Ratio15.50
Quick Ratio15.50
Target$80.50
Target Upside207.13%
Target Median$80.50
Target Range64.00 - 97.00
Volume643.47K
Avg Volume850.29K
EPS Surprise-0.02
Investment DNA
How strong this company looks for long-term investors
45
out of 100
Business Quality
Margins, moat, returns
27/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
62/100
Why this score▼
Manageable debt level · 0.07Healthy liquidity · 15.5Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 6 analyst votes · 2026-09-05
100/100
Bullish
Bullish
6
Hold
0
Bearish
0
Price Target
2026-06-25
Low
$46.00
Mean
$69.00
Median
$64.00
High
$97.00
Insider Transactions
Recent executive and insider activity
Coloma Jason V
Transaction: 06/22/2026
SELL
Change
-2,040
Price
$26.00
Filing
06/24/2026
Type
SELL
Andrews Nancy C
Transaction: 06/08/2026
BUY
Change
+18,000
Price
$23.58
Filing
06/10/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Coloma Jason V | SELL | -23,865 | $26.05 | 06/23/2026 | 06/24/2026 |
| Coloma Jason V | SELL | -2,040 | $26.00 | 06/22/2026 | 06/24/2026 |
| Andrews Nancy C | BUY | +18,000 | $23.58 | 06/08/2026 | 06/10/2026 |
| HOMCY CHARLES J | BUY | +18,000 | $23.58 | 06/08/2026 | 06/10/2026 |
| Hoppenot Herve | BUY | +18,000 | $23.58 | 06/08/2026 | 06/10/2026 |
| Lim Jonathan E | BUY | +18,000 | $23.58 | 06/08/2026 | 06/10/2026 |
| SCHELLER RICHARD H | BUY | +18,000 | $23.58 | 06/08/2026 | 06/10/2026 |
| SPIEGELMAN DANIEL K | BUY | +18,000 | $23.58 | 06/08/2026 | 06/10/2026 |
| Bernstein Harold | SELL | -1,600 | $26.36 | 06/01/2026 | 06/03/2026 |
| Bernstein Harold | SELL | -14,853 | $10.42 | 06/01/2026 | 06/03/2026 |
| Coloma Jason V | SELL | -553 | $26.24 | 06/01/2026 | 06/03/2026 |
| Dandekar Atul | SELL | -7,500 | $26.34 | 05/29/2026 | 06/02/2026 |
| Dandekar Atul | SELL | -7,500 | $10.42 | 05/29/2026 | 06/02/2026 |
| Coloma Jason V | SELL | -25,582 | $26.02 | 05/26/2026 | 05/27/2026 |
| Coloma Jason V | SELL | -2,478 | $26.00 | 05/22/2026 | 05/27/2026 |
| Coloma Jason V | SELL | -116 | $26.00 | 05/15/2026 | 05/18/2026 |
| Bernstein Harold | SELL | -15,000 | $26.22 | 05/14/2026 | 05/18/2026 |
| Bernstein Harold | SELL | -15,000 | $10.42 | 05/14/2026 | 05/18/2026 |
| HOMCY CHARLES J | SELL | -7,422 | Not reported | 05/04/2026 | 05/06/2026 |
| Dandekar Atul | BUY | +8,320 | $10.42 | 05/04/2026 | 05/06/2026 |